Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meijer

Showing results (291-300 of 378) with videos related to

Pageof 38
Sort By:
Journal of Proteomics|October 22, 2018
Strategies for managing multi-patient 3D mass spectrometry imaging dataD R N Vos, I Jansen, M Lucas, et al.
Surgical Endoscopy|October 19, 2019
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective studyEliza R C Hagens, Hannah T Künzli, Anne-Sophie van Rijswijk, et al.
Cancers|January 21, 2022
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N C Boyd, Mahsoem Ali, Laura Kam, et al.
Human Pathology|November 22, 2020
Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus surveyG Saliba, S Detlefsen, F Carneiro, et al.
United European Gastroenterology Journal|July 6, 2021
Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progressionEsther Klaver, Angela Bureo Gonzalez, Nahid Mostafavi, et al.
Cancer Science|April 30, 2024
In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulationsErnesto Rodriguez, Eline S Zwart, Alsya A Affandi, et al.
Journal of Gastrointestinal Cancer|July 1, 2023
<sup>18</sup>F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term ImplicationsD C van der Aa, S S Gisbertz, M C J Anderegg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 2, 2017
Treatment strategies in recurrent esophageal or junctional cancerR Butter, S M Lagarde, M G H van Oijen, et al.
Plos One|August 5, 2015
Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in MacrophagesAnouk A J Hamers, Laura van Dam, José M Teixeira Duarte, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT studySil Kordes, Mark I van Berge Henegouwen, Maarten C Hulshof, et al.
Pageof 38

Showing results (291-300 of 378) with videos related to

Sort By:
Pageof 38
Journal of Proteomics|October 22, 2018
Strategies for managing multi-patient 3D mass spectrometry imaging dataD R N Vos, I Jansen, M Lucas, et al.
Surgical Endoscopy|October 19, 2019
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective studyEliza R C Hagens, Hannah T Künzli, Anne-Sophie van Rijswijk, et al.
Cancers|January 21, 2022
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N C Boyd, Mahsoem Ali, Laura Kam, et al.
Human Pathology|November 22, 2020
Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus surveyG Saliba, S Detlefsen, F Carneiro, et al.
United European Gastroenterology Journal|July 6, 2021
Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progressionEsther Klaver, Angela Bureo Gonzalez, Nahid Mostafavi, et al.
Cancer Science|April 30, 2024
In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulationsErnesto Rodriguez, Eline S Zwart, Alsya A Affandi, et al.
Journal of Gastrointestinal Cancer|July 1, 2023
<sup>18</sup>F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term ImplicationsD C van der Aa, S S Gisbertz, M C J Anderegg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 2, 2017
Treatment strategies in recurrent esophageal or junctional cancerR Butter, S M Lagarde, M G H van Oijen, et al.
Plos One|August 5, 2015
Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in MacrophagesAnouk A J Hamers, Laura van Dam, José M Teixeira Duarte, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT studySil Kordes, Mark I van Berge Henegouwen, Maarten C Hulshof, et al.
Pageof 38